Skip to main content

Published locations for Phase 2 Results: Zerlasiran siRNA Drug Lowers Lp(a) by 90%

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Phase 2 Results: Zerlasiran siRNA Drug Lowers Lp(a) by 90%

User login

  • Reset your password
  • /content/phase-2-results-zerlasiran-sirna-drug-lowers-lpa-90
  • /clinicianreviews/article/268324/lipid-disorders/phase-2-results-zerlasiran-sirna-drug-lowers-lpa-90
  • /familypracticenews/article/268324/lipid-disorders/phase-2-results-zerlasiran-sirna-drug-lowers-lpa
  • /fedprac/article/268324/lipid-disorders/phase-2-results-zerlasiran-sirna-drug-lowers-lpa-90
  • /internalmedicinenews/article/268324/lipid-disorders/phase-2-results-zerlasiran-sirna-drug-lowers-lpa
  • /ecardiologynews/article/268324/lipid-disorders/phase-2-results-zerlasiran-sirna-drug-lowers-lpa-90
  • /cardiology/article/268324/lipid-disorders/phase-2-results-zerlasiran-sirna-drug-lowers-lpa-90
  • /internalmedicine/article/268324/lipid-disorders/phase-2-results-zerlasiran-sirna-drug-lowers-lpa-90
  • /familymedicine/article/268324/lipid-disorders/phase-2-results-zerlasiran-sirna-drug-lowers-lpa-90
  • /chestphysician/article/268324/lipid-disorders/phase-2-results-zerlasiran-sirna-drug-lowers-lpa-90